Hamburg AoRtic Valve cOhoRt

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Jan 9, 2020

Keywords

ClinConnect Summary

The Hamburg AoRtic Valve cOhoRt trial is a study aimed at finding the best treatments for patients with aortic valve disease, which includes conditions like aortic valve stenosis (narrowing of the valve) and aortic regurgitation (leaking of the valve). The researchers want to understand how different factors, such as a patient's age, medical history, and specific test results, can affect treatment outcomes. The study is currently looking for participants who are between 65 and 74 years old and can speak and write in German.

To take part in this trial, patients must have significant aortic valve disease and be able to give written consent. Those who cannot understand or communicate in German, or who have physical or mental health issues that would prevent them from participating, will not be eligible. Participants can expect to contribute to important research that may help improve future treatments for aortic valve disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)
• • Written informed consent
• Exclusion Criteria:
• • Insufficient knowledge of the German language (able to understand and write the German language)
• • Physical or psychological incapability to take part in the investigation